However, studies to date seem to indicate that inhibiting the reduction of Cx43 in joint tissues might be beneficial in preventing the progression of joint diseases, taking into account the inflammatory component of the disease pathologies as well as the relevant role of MMPs in these pathologies [64, 81]. This evidence concerns the gene GJA1 and arthropathy.